244 related articles for article (PubMed ID: 35122369)
1. Chronic hepatitis D-What is changing?
Yardeni D; Heller T; Koh C
J Viral Hepat; 2022 Apr; 29(4):240-251. PubMed ID: 35122369
[TBL] [Abstract][Full Text] [Related]
2. New Treatments for Chronic Hepatitis B Virus/Hepatitis D Virus Infection.
Sandmann L; Wedemeyer H
Clin Liver Dis; 2021 Nov; 25(4):831-839. PubMed ID: 34593156
[TBL] [Abstract][Full Text] [Related]
3. Emerging concepts for the treatment of hepatitis delta.
Elazar M; Glenn JS
Curr Opin Virol; 2017 Jun; 24():55-59. PubMed ID: 28475945
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis delta and HIV infection.
Soriano V; Sherman KE; Barreiro P
AIDS; 2017 Apr; 31(7):875-884. PubMed ID: 28121714
[TBL] [Abstract][Full Text] [Related]
5. Emerging drugs for hepatitis D.
Keskin O; Yurdaydin C
Expert Opin Emerg Drugs; 2023 Dec; 28(2):55-66. PubMed ID: 37096555
[TBL] [Abstract][Full Text] [Related]
6. Bulevirtide and emerging drugs for the treatment of hepatitis D.
Xu HY; Yang JO; Chen PH; Han SB
Expert Opin Biol Ther; 2023; 23(12):1245-1253. PubMed ID: 37853604
[TBL] [Abstract][Full Text] [Related]
7. Beyond Pegylated Interferon-Alpha: New Treatments for Hepatitis Delta.
Deterding K; Wedemeyer H
AIDS Rev; 2019; 21(3):126-134. PubMed ID: 31532397
[TBL] [Abstract][Full Text] [Related]
8. Bulevirtide with or without pegIFNα for patients with compensated chronic hepatitis delta: From clinical trials to real-world studies.
Lampertico P; Roulot D; Wedemeyer H
J Hepatol; 2022 Nov; 77(5):1422-1430. PubMed ID: 35752223
[TBL] [Abstract][Full Text] [Related]
9. HBV/HDV Coinfection: A Challenge for Therapeutics.
Koh C; Da BL; Glenn JS
Clin Liver Dis; 2019 Aug; 23(3):557-572. PubMed ID: 31266627
[TBL] [Abstract][Full Text] [Related]
10. Bulevirtide: First Approval.
Kang C; Syed YY
Drugs; 2020 Oct; 80(15):1601-1605. PubMed ID: 32926353
[TBL] [Abstract][Full Text] [Related]
11. Beyond bulevirtide: Alternative therapeutic options for the management of hepatitis delta virus.
Asselah T
J Viral Hepat; 2023 Apr; 30 Suppl 1():33-38. PubMed ID: 36529713
[TBL] [Abstract][Full Text] [Related]
12. Treatment of Chronic Hepatitis D with Bulevirtide-A Fight against Two Foes-An Update.
Ferenci P; Reiberger T; Jachs M
Cells; 2022 Nov; 11(22):. PubMed ID: 36428959
[TBL] [Abstract][Full Text] [Related]
13. What is the Path Forward to Treat Hepatitis Delta Virus?: Old Treatments and New Options.
Asselah T
Clin Liver Dis; 2023 Nov; 27(4):985-995. PubMed ID: 37778781
[TBL] [Abstract][Full Text] [Related]
14. Combination of Novel Therapies for HDV.
Elazar M; Glenn JS
Viruses; 2022 Jan; 14(2):. PubMed ID: 35215860
[TBL] [Abstract][Full Text] [Related]
15. Mathematical modeling suggests that entry-inhibitor bulevirtide may interfere with hepatitis D virus clearance from circulation.
Shekhtman L; Cotler SJ; Ploss A; Dahari H
J Hepatol; 2022 May; 76(5):1229-1231. PubMed ID: 34995688
[No Abstract] [Full Text] [Related]
16. Hepatitis D virus: Improving virological knowledge to develop new treatments.
Khalfi P; Kennedy PT; Majzoub K; Asselah T
Antiviral Res; 2023 Jan; 209():105461. PubMed ID: 36396025
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis D virus in 2021: virology, immunology and new treatment approaches for a difficult-to-treat disease.
Urban S; Neumann-Haefelin C; Lampertico P
Gut; 2021 Sep; 70(9):1782-1794. PubMed ID: 34103404
[TBL] [Abstract][Full Text] [Related]
18. Bulevirtide monotherapy for 48 weeks in patients with HDV-related compensated cirrhosis and clinically significant portal hypertension.
Degasperi E; Anolli MP; Uceda Renteria SC; Sambarino D; Borghi M; Perbellini R; Scholtes C; Facchetti F; Loglio A; Monico S; Fraquelli M; Costantino A; Ceriotti F; Zoulim F; Lampertico P
J Hepatol; 2022 Dec; 77(6):1525-1531. PubMed ID: 35973578
[TBL] [Abstract][Full Text] [Related]
19. Treatment of hepatitis D: an unmet medical need.
Caviglia GP; Rizzetto M
Clin Microbiol Infect; 2020 Jul; 26(7):824-827. PubMed ID: 32120043
[TBL] [Abstract][Full Text] [Related]
20. New treatment options for delta virus: Is a cure in sight?
Yurdaydin C
J Viral Hepat; 2019 Jun; 26(6):618-626. PubMed ID: 30771261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
